Results 101 to 110 of about 4,877,549 (387)

Rapid Fabrication of Self‐Propelled and Steerable Magnetic Microcatheters for Precision Medicine

open access: yesAdvanced Materials, EarlyView.
A rapid Joule heating fabrication method for the production of self‐propelling, adaptive microcatheters, with tunable stiffness and integrated microfluidic channels is presented. Demonstrated through three microrobotic designs, including a steerable guiding catheter, an untethered wave‐crawling TubeBot, and a distal‐end propelled microcatheter, it was ...
Zhi Chen   +5 more
wiley   +1 more source

Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: A cross-sectional online survey [PDF]

open access: yes, 2019
BACKGROUND: Epigenetic markers might be used for risk-stratifying cancer screening and prevention programs in the future. Although the clinical utility of consequent epigenetic tests for risk stratification is yet to be proven, successful adoption into ...
Pashayan, N.   +3 more
core   +1 more source

Hydrogel Confinement Strategies for 3D Cell Culture in Microfluidic Systems

open access: yesAdvanced Materials Technologies, EarlyView.
Hydrogel confinement structures are key to organizing 3D cell cultures in microfluidic devices. This review classifies five structural strategies (micropillar, phaseguide, porous membrane, stepped‐height, and support‐free) and examines their trade‐offs alongside fabrication methods.
Soohyun Kim, Min Seok Lee, Sung Kyun Lee
wiley   +1 more source

The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland [PDF]

open access: yes, 2002
No abstract ...
Crawford, S.C.   +6 more
core   +2 more sources

The histological type of endometrial cancer is not associated with menopause status at diagnosis [PDF]

open access: gold, 2022
Xinyi Sun   +6 more
openalex   +1 more source

A Review of Immune Checkpoint Blockade Therapy in Endometrial Cancer.

open access: yesAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2020
Approximately 30% of primary endometrial cancers are microsatellite instability high/hypermutated (MSI-H), and 13% to 30% of recurrent endometrial cancers are MSI-H or mismatch repair deficient (dMMR).
A. Green, J. Feinberg, V. Makker
semanticscholar   +1 more source

Engineered Microfluidic Organoid Systems: New Paradigms for Menopause Mechanism Research and Personalized Medicine

open access: yesAdvanced Materials Technologies, EarlyView.
This review explores the integration of microfluidic technology with organoid systems as an innovative platform for studying menopausea complex multi‐organ condition. By enabling precise simulation of inter‐organ communication and hormone responses, microfluidic organoids offer a physiologically relevant model for investigating menopausal syndrome and ...
Qianyi Zhang   +4 more
wiley   +1 more source

Prognostic factors for rural endometrial cancer patients in a population-based cohort

open access: yesBMC Public Health, 2019
Background Endometrial cancer is the second most common cancer among female cancer survivors in the US and is increasing in incidence. Rural endometrial cancer patients experience lower survival rates but the reasons for the lower survival are not known.
Brenna E. Blackburn   +14 more
doaj   +1 more source

Tamoxifen and Assymptomatic Endometrial Thickness [PDF]

open access: yes, 2008
Tamoxifen is a first-line agent for adjuvant treatment of estrogen-receptor positive breast cancer, and is used to reduce the risk of this condition in high-risk individuals.
Amaral, N, Fatela, A, Robalo, R
core  

Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay. [PDF]

open access: yes, 2017
BackgroundGlucocorticoid receptor (GR) activity plays a role in many aspects of human physiology and may play a crucial role in chemotherapy resistance in a wide variety of solid tumors.
Block, Thaddeus S   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy